See also
this year's filing and
all EDGAR filings for this company.
PDF Report 0000810509_2023_Navidea_Biopharmaceuticals_Inc.pdf
Logs
| warning |
The stock price does not exist |
industry.us_generic |
{} |
| info |
Failed to set obs_EconomicCapitalRatio |
industry.us_generic |
{'reason': "KeyError('0000810509')"} |
Graph
Absolute values for 0000810509, Navidea Biopharmaceuticals Inc
| |
xvar |
xval |
| 0 |
LiabilitiesNoncurrent |
1,312 |
| 1 |
LiabilitiesCurrent |
9,941,889 |
| 2 |
remainder_Liabilities |
2,571,715 |
| 3 |
AssetsCurrent |
3,203,944 |
| 4 |
AssetsNoncurrent |
32,074 |
| 5 |
PropertyPlantAndEquipmentNet |
135,347 |
| 6 |
Goodwill |
1,000,241 |
| 7 |
remainder_Assets |
0 |
| 8 |
GeneralAndAdministrativeExpense |
7,963,767 |
| 9 |
ResearchAndDevelopmentExpense |
5,969,774 |
| 10 |
remainder_Expenses |
183,006 |
| 11 |
remainder_Revenues |
65,652 |
| 12 |
remainder_NetIncome |
-1,126,261 |
| 13 |
remainder_ComprehensiveNetIncome |
0 |
| |
yvar |
yval |
| 0 |
Liabilities |
12,514,916 |
| 1 |
Assets |
4,371,606 |
| 2 |
Expenses |
14,116,547 |
| 3 |
Revenues |
65,652 |
| 4 |
StockholdersEquity |
-8,143,310 |
| 5 |
NetIncome |
-15,177,156 |
| 6 |
ComprehensiveNetIncome |
-15,177,156 |
| 7 |
BaseVar |
16,097,491 |
| 8 |
EconomicCapitalRatiobeforeLimitedLiability |
-3.12 |
| 9 |
EconomicCapitalRatio |
0.0974 |
Edgar->Model Mapping
Feature Distribution
Change over Time
